Three blood tests split advanced prostate cancer patients by survival risk, a study found
Researchers trained a model on baseline data from 2,035 patients with metastatic castration-resistant prostate cancer. They used unsupervised machine learning to find subgroups with different survival, then reduced the findings to a score called PROGRESS.
JCO Clinical Cancer Informatics
ace